Medical Care
Global Pediatric Respiratory Disease Therapeutics Market Research Report 2025
- Jul 08, 25
- ID: 347791
- Pages: 78
- Figures: 72
- Views: 27
The global market for Pediatric Respiratory Disease Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pediatric Respiratory Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Respiratory Disease Therapeutics.
The Pediatric Respiratory Disease Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Respiratory Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Respiratory Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Bayer AG
GSK
Merck
Boehringer Ingelheim
Regeneron Pharmaceuticals
AstraZeneca
Roche
Segment by Type
Anti-Inflammatory Drugs
Bronchodilators
Combination Drugs
Corticosteroid
Monoclonal Antibodies
Others
Segment by Application
Asthma
Cystic Fibrosis
Bronchiolitis
Pneumonia
Idiopathic Pulmonary Fibrosis
Tuberculosis
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Respiratory Disease Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pediatric Respiratory Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Respiratory Disease Therapeutics.
The Pediatric Respiratory Disease Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Respiratory Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Respiratory Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Bayer AG
GSK
Merck
Boehringer Ingelheim
Regeneron Pharmaceuticals
AstraZeneca
Roche
Segment by Type
Anti-Inflammatory Drugs
Bronchodilators
Combination Drugs
Corticosteroid
Monoclonal Antibodies
Others
Segment by Application
Asthma
Cystic Fibrosis
Bronchiolitis
Pneumonia
Idiopathic Pulmonary Fibrosis
Tuberculosis
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Respiratory Disease Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Anti-Inflammatory Drugs
1.2.3 Bronchodilators
1.2.4 Combination Drugs
1.2.5 Corticosteroid
1.2.6 Monoclonal Antibodies
1.2.7 Others
1.3 Market by Application
1.3.1 Global Pediatric Respiratory Disease Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Asthma
1.3.3 Cystic Fibrosis
1.3.4 Bronchiolitis
1.3.5 Pneumonia
1.3.6 Idiopathic Pulmonary Fibrosis
1.3.7 Tuberculosis
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Respiratory Disease Therapeutics Market Perspective (2020-2031)
2.2 Global Pediatric Respiratory Disease Therapeutics Growth Trends by Region
2.2.1 Global Pediatric Respiratory Disease Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pediatric Respiratory Disease Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Pediatric Respiratory Disease Therapeutics Market Dynamics
2.3.1 Pediatric Respiratory Disease Therapeutics Industry Trends
2.3.2 Pediatric Respiratory Disease Therapeutics Market Drivers
2.3.3 Pediatric Respiratory Disease Therapeutics Market Challenges
2.3.4 Pediatric Respiratory Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Respiratory Disease Therapeutics Players by Revenue
3.1.1 Global Top Pediatric Respiratory Disease Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Pediatric Respiratory Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric Respiratory Disease Therapeutics Revenue
3.4 Global Pediatric Respiratory Disease Therapeutics Market Concentration Ratio
3.4.1 Global Pediatric Respiratory Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Respiratory Disease Therapeutics Revenue in 2024
3.5 Global Key Players of Pediatric Respiratory Disease Therapeutics Head office and Area Served
3.6 Global Key Players of Pediatric Respiratory Disease Therapeutics, Product and Application
3.7 Global Key Players of Pediatric Respiratory Disease Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Respiratory Disease Therapeutics Breakdown Data by Type
4.1 Global Pediatric Respiratory Disease Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Type (2026-2031)
5 Pediatric Respiratory Disease Therapeutics Breakdown Data by Application
5.1 Global Pediatric Respiratory Disease Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pediatric Respiratory Disease Therapeutics Market Size (2020-2031)
6.2 North America Pediatric Respiratory Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025)
6.4 North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Respiratory Disease Therapeutics Market Size (2020-2031)
7.2 Europe Pediatric Respiratory Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025)
7.4 Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Respiratory Disease Therapeutics Market Size (2020-2031)
9.2 Latin America Pediatric Respiratory Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Pediatric Respiratory Disease Therapeutics Introduction
11.1.4 Novartis AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Pediatric Respiratory Disease Therapeutics Introduction
11.2.4 Bayer AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.2.5 Bayer AG Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Pediatric Respiratory Disease Therapeutics Introduction
11.3.4 GSK Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.3.5 GSK Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Pediatric Respiratory Disease Therapeutics Introduction
11.4.4 Merck Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Pediatric Respiratory Disease Therapeutics Introduction
11.5.4 Boehringer Ingelheim Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Details
11.6.2 Regeneron Pharmaceuticals Business Overview
11.6.3 Regeneron Pharmaceuticals Pediatric Respiratory Disease Therapeutics Introduction
11.6.4 Regeneron Pharmaceuticals Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.6.5 Regeneron Pharmaceuticals Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Pediatric Respiratory Disease Therapeutics Introduction
11.7.4 AstraZeneca Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Pediatric Respiratory Disease Therapeutics Introduction
11.8.4 Roche Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.8.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Anti-Inflammatory Drugs
1.2.3 Bronchodilators
1.2.4 Combination Drugs
1.2.5 Corticosteroid
1.2.6 Monoclonal Antibodies
1.2.7 Others
1.3 Market by Application
1.3.1 Global Pediatric Respiratory Disease Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Asthma
1.3.3 Cystic Fibrosis
1.3.4 Bronchiolitis
1.3.5 Pneumonia
1.3.6 Idiopathic Pulmonary Fibrosis
1.3.7 Tuberculosis
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Respiratory Disease Therapeutics Market Perspective (2020-2031)
2.2 Global Pediatric Respiratory Disease Therapeutics Growth Trends by Region
2.2.1 Global Pediatric Respiratory Disease Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pediatric Respiratory Disease Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Pediatric Respiratory Disease Therapeutics Market Dynamics
2.3.1 Pediatric Respiratory Disease Therapeutics Industry Trends
2.3.2 Pediatric Respiratory Disease Therapeutics Market Drivers
2.3.3 Pediatric Respiratory Disease Therapeutics Market Challenges
2.3.4 Pediatric Respiratory Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Respiratory Disease Therapeutics Players by Revenue
3.1.1 Global Top Pediatric Respiratory Disease Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Pediatric Respiratory Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric Respiratory Disease Therapeutics Revenue
3.4 Global Pediatric Respiratory Disease Therapeutics Market Concentration Ratio
3.4.1 Global Pediatric Respiratory Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Respiratory Disease Therapeutics Revenue in 2024
3.5 Global Key Players of Pediatric Respiratory Disease Therapeutics Head office and Area Served
3.6 Global Key Players of Pediatric Respiratory Disease Therapeutics, Product and Application
3.7 Global Key Players of Pediatric Respiratory Disease Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Respiratory Disease Therapeutics Breakdown Data by Type
4.1 Global Pediatric Respiratory Disease Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Type (2026-2031)
5 Pediatric Respiratory Disease Therapeutics Breakdown Data by Application
5.1 Global Pediatric Respiratory Disease Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pediatric Respiratory Disease Therapeutics Market Size (2020-2031)
6.2 North America Pediatric Respiratory Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025)
6.4 North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Respiratory Disease Therapeutics Market Size (2020-2031)
7.2 Europe Pediatric Respiratory Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025)
7.4 Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Respiratory Disease Therapeutics Market Size (2020-2031)
9.2 Latin America Pediatric Respiratory Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Pediatric Respiratory Disease Therapeutics Introduction
11.1.4 Novartis AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Pediatric Respiratory Disease Therapeutics Introduction
11.2.4 Bayer AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.2.5 Bayer AG Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Pediatric Respiratory Disease Therapeutics Introduction
11.3.4 GSK Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.3.5 GSK Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Pediatric Respiratory Disease Therapeutics Introduction
11.4.4 Merck Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Pediatric Respiratory Disease Therapeutics Introduction
11.5.4 Boehringer Ingelheim Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Details
11.6.2 Regeneron Pharmaceuticals Business Overview
11.6.3 Regeneron Pharmaceuticals Pediatric Respiratory Disease Therapeutics Introduction
11.6.4 Regeneron Pharmaceuticals Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.6.5 Regeneron Pharmaceuticals Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Pediatric Respiratory Disease Therapeutics Introduction
11.7.4 AstraZeneca Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Pediatric Respiratory Disease Therapeutics Introduction
11.8.4 Roche Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
11.8.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Anti-Inflammatory Drugs
Table 3. Key Players of Bronchodilators
Table 4. Key Players of Combination Drugs
Table 5. Key Players of Corticosteroid
Table 6. Key Players of Monoclonal Antibodies
Table 7. Key Players of Others
Table 8. Global Pediatric Respiratory Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Pediatric Respiratory Disease Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Pediatric Respiratory Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Pediatric Respiratory Disease Therapeutics Market Share by Region (2020-2025)
Table 12. Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Pediatric Respiratory Disease Therapeutics Market Share by Region (2026-2031)
Table 14. Pediatric Respiratory Disease Therapeutics Market Trends
Table 15. Pediatric Respiratory Disease Therapeutics Market Drivers
Table 16. Pediatric Respiratory Disease Therapeutics Market Challenges
Table 17. Pediatric Respiratory Disease Therapeutics Market Restraints
Table 18. Global Pediatric Respiratory Disease Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Pediatric Respiratory Disease Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top Pediatric Respiratory Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Respiratory Disease Therapeutics as of 2024)
Table 21. Ranking of Global Top Pediatric Respiratory Disease Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Pediatric Respiratory Disease Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Pediatric Respiratory Disease Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of Pediatric Respiratory Disease Therapeutics, Product and Application
Table 25. Global Key Players of Pediatric Respiratory Disease Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pediatric Respiratory Disease Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Type (2020-2025)
Table 29. Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Type (2026-2031)
Table 31. Global Pediatric Respiratory Disease Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Application (2020-2025)
Table 33. Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Application (2026-2031)
Table 35. North America Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 50. Novartis AG Company Details
Table 51. Novartis AG Business Overview
Table 52. Novartis AG Pediatric Respiratory Disease Therapeutics Product
Table 53. Novartis AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 54. Novartis AG Recent Development
Table 55. Bayer AG Company Details
Table 56. Bayer AG Business Overview
Table 57. Bayer AG Pediatric Respiratory Disease Therapeutics Product
Table 58. Bayer AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 59. Bayer AG Recent Development
Table 60. GSK Company Details
Table 61. GSK Business Overview
Table 62. GSK Pediatric Respiratory Disease Therapeutics Product
Table 63. GSK Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 64. GSK Recent Development
Table 65. Merck Company Details
Table 66. Merck Business Overview
Table 67. Merck Pediatric Respiratory Disease Therapeutics Product
Table 68. Merck Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 69. Merck Recent Development
Table 70. Boehringer Ingelheim Company Details
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Pediatric Respiratory Disease Therapeutics Product
Table 73. Boehringer Ingelheim Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 74. Boehringer Ingelheim Recent Development
Table 75. Regeneron Pharmaceuticals Company Details
Table 76. Regeneron Pharmaceuticals Business Overview
Table 77. Regeneron Pharmaceuticals Pediatric Respiratory Disease Therapeutics Product
Table 78. Regeneron Pharmaceuticals Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 79. Regeneron Pharmaceuticals Recent Development
Table 80. AstraZeneca Company Details
Table 81. AstraZeneca Business Overview
Table 82. AstraZeneca Pediatric Respiratory Disease Therapeutics Product
Table 83. AstraZeneca Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 84. AstraZeneca Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Pediatric Respiratory Disease Therapeutics Product
Table 88. Roche Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 89. Roche Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Authors List of This Report
List of Figures
Figure 1. Pediatric Respiratory Disease Therapeutics Picture
Figure 2. Global Pediatric Respiratory Disease Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pediatric Respiratory Disease Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Anti-Inflammatory Drugs Features
Figure 5. Bronchodilators Features
Figure 6. Combination Drugs Features
Figure 7. Corticosteroid Features
Figure 8. Monoclonal Antibodies Features
Figure 9. Others Features
Figure 10. Global Pediatric Respiratory Disease Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Pediatric Respiratory Disease Therapeutics Market Share by Application: 2024 VS 2031
Figure 12. Asthma Case Studies
Figure 13. Cystic Fibrosis Case Studies
Figure 14. Bronchiolitis Case Studies
Figure 15. Pneumonia Case Studies
Figure 16. Idiopathic Pulmonary Fibrosis Case Studies
Figure 17. Tuberculosis Case Studies
Figure 18. Others Case Studies
Figure 19. Pediatric Respiratory Disease Therapeutics Report Years Considered
Figure 20. Global Pediatric Respiratory Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 21. Global Pediatric Respiratory Disease Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 22. Global Pediatric Respiratory Disease Therapeutics Market Share by Region: 2024 VS 2031
Figure 23. Global Pediatric Respiratory Disease Therapeutics Market Share by Players in 2024
Figure 24. Global Top Pediatric Respiratory Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Respiratory Disease Therapeutics as of 2024)
Figure 25. The Top 10 and 5 Players Market Share by Pediatric Respiratory Disease Therapeutics Revenue in 2024
Figure 26. North America Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. North America Pediatric Respiratory Disease Therapeutics Market Share by Country (2020-2031)
Figure 28. United States Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Canada Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe Pediatric Respiratory Disease Therapeutics Market Share by Country (2020-2031)
Figure 32. Germany Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. France Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. U.K. Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Italy Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Russia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Nordic Countries Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Share by Region (2020-2031)
Figure 40. China Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Japan Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. South Korea Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. India Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Australia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America Pediatric Respiratory Disease Therapeutics Market Share by Country (2020-2031)
Figure 48. Mexico Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Brazil Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Share by Country (2020-2031)
Figure 52. Turkey Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. UAE Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Novartis AG Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 56. Bayer AG Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 57. GSK Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 58. Merck Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 60. Regeneron Pharmaceuticals Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 61. AstraZeneca Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 62. Roche Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Anti-Inflammatory Drugs
Table 3. Key Players of Bronchodilators
Table 4. Key Players of Combination Drugs
Table 5. Key Players of Corticosteroid
Table 6. Key Players of Monoclonal Antibodies
Table 7. Key Players of Others
Table 8. Global Pediatric Respiratory Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Pediatric Respiratory Disease Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Pediatric Respiratory Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Pediatric Respiratory Disease Therapeutics Market Share by Region (2020-2025)
Table 12. Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Pediatric Respiratory Disease Therapeutics Market Share by Region (2026-2031)
Table 14. Pediatric Respiratory Disease Therapeutics Market Trends
Table 15. Pediatric Respiratory Disease Therapeutics Market Drivers
Table 16. Pediatric Respiratory Disease Therapeutics Market Challenges
Table 17. Pediatric Respiratory Disease Therapeutics Market Restraints
Table 18. Global Pediatric Respiratory Disease Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Pediatric Respiratory Disease Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top Pediatric Respiratory Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Respiratory Disease Therapeutics as of 2024)
Table 21. Ranking of Global Top Pediatric Respiratory Disease Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Pediatric Respiratory Disease Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Pediatric Respiratory Disease Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of Pediatric Respiratory Disease Therapeutics, Product and Application
Table 25. Global Key Players of Pediatric Respiratory Disease Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pediatric Respiratory Disease Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Type (2020-2025)
Table 29. Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Type (2026-2031)
Table 31. Global Pediatric Respiratory Disease Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Application (2020-2025)
Table 33. Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Application (2026-2031)
Table 35. North America Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 50. Novartis AG Company Details
Table 51. Novartis AG Business Overview
Table 52. Novartis AG Pediatric Respiratory Disease Therapeutics Product
Table 53. Novartis AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 54. Novartis AG Recent Development
Table 55. Bayer AG Company Details
Table 56. Bayer AG Business Overview
Table 57. Bayer AG Pediatric Respiratory Disease Therapeutics Product
Table 58. Bayer AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 59. Bayer AG Recent Development
Table 60. GSK Company Details
Table 61. GSK Business Overview
Table 62. GSK Pediatric Respiratory Disease Therapeutics Product
Table 63. GSK Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 64. GSK Recent Development
Table 65. Merck Company Details
Table 66. Merck Business Overview
Table 67. Merck Pediatric Respiratory Disease Therapeutics Product
Table 68. Merck Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 69. Merck Recent Development
Table 70. Boehringer Ingelheim Company Details
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Pediatric Respiratory Disease Therapeutics Product
Table 73. Boehringer Ingelheim Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 74. Boehringer Ingelheim Recent Development
Table 75. Regeneron Pharmaceuticals Company Details
Table 76. Regeneron Pharmaceuticals Business Overview
Table 77. Regeneron Pharmaceuticals Pediatric Respiratory Disease Therapeutics Product
Table 78. Regeneron Pharmaceuticals Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 79. Regeneron Pharmaceuticals Recent Development
Table 80. AstraZeneca Company Details
Table 81. AstraZeneca Business Overview
Table 82. AstraZeneca Pediatric Respiratory Disease Therapeutics Product
Table 83. AstraZeneca Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 84. AstraZeneca Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Pediatric Respiratory Disease Therapeutics Product
Table 88. Roche Revenue in Pediatric Respiratory Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 89. Roche Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Authors List of This Report
List of Figures
Figure 1. Pediatric Respiratory Disease Therapeutics Picture
Figure 2. Global Pediatric Respiratory Disease Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pediatric Respiratory Disease Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Anti-Inflammatory Drugs Features
Figure 5. Bronchodilators Features
Figure 6. Combination Drugs Features
Figure 7. Corticosteroid Features
Figure 8. Monoclonal Antibodies Features
Figure 9. Others Features
Figure 10. Global Pediatric Respiratory Disease Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Pediatric Respiratory Disease Therapeutics Market Share by Application: 2024 VS 2031
Figure 12. Asthma Case Studies
Figure 13. Cystic Fibrosis Case Studies
Figure 14. Bronchiolitis Case Studies
Figure 15. Pneumonia Case Studies
Figure 16. Idiopathic Pulmonary Fibrosis Case Studies
Figure 17. Tuberculosis Case Studies
Figure 18. Others Case Studies
Figure 19. Pediatric Respiratory Disease Therapeutics Report Years Considered
Figure 20. Global Pediatric Respiratory Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 21. Global Pediatric Respiratory Disease Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 22. Global Pediatric Respiratory Disease Therapeutics Market Share by Region: 2024 VS 2031
Figure 23. Global Pediatric Respiratory Disease Therapeutics Market Share by Players in 2024
Figure 24. Global Top Pediatric Respiratory Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Respiratory Disease Therapeutics as of 2024)
Figure 25. The Top 10 and 5 Players Market Share by Pediatric Respiratory Disease Therapeutics Revenue in 2024
Figure 26. North America Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. North America Pediatric Respiratory Disease Therapeutics Market Share by Country (2020-2031)
Figure 28. United States Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Canada Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe Pediatric Respiratory Disease Therapeutics Market Share by Country (2020-2031)
Figure 32. Germany Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. France Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. U.K. Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Italy Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Russia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Nordic Countries Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Share by Region (2020-2031)
Figure 40. China Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Japan Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. South Korea Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. India Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Australia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America Pediatric Respiratory Disease Therapeutics Market Share by Country (2020-2031)
Figure 48. Mexico Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Brazil Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Share by Country (2020-2031)
Figure 52. Turkey Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. UAE Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Novartis AG Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 56. Bayer AG Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 57. GSK Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 58. Merck Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 60. Regeneron Pharmaceuticals Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 61. AstraZeneca Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 62. Roche Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232